Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Emerson Electric $3 billion notes offering
The investment-grade notes are due 2028, 2031 and 2051
Legend Biotech $345 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Dun & Bradstreet $460 million senior notes offering
The high-yield notes are due 2029
Dynamics Special Purpose $601 million combination with Senti Biosciences
We are advising Dynamics, a SPAC, on the transaction
Focus Financial Partners $176 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Hexion Holdings acquisition by American Securities
We are advising Hexion on the transaction
Strategic Value Partners tender offer for Washington Prime Group stapled units
We advised Strategic Value Partners on the cash tender offer by two funds it manages
Searchlight Capital / Marcus JV to acquire Kimpton hotel in Pittsburgh
We advised the joint venture on the transaction
Ancestry.com $250 million senior notes offering
The high-yield notes are due 2028
Swiftmerge Acquisition $200 million IPO
The issuer, a SPAC, offered 20,000,000 units which were listed on Nasdaq